Clinical Trial Update: A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance Therapy [Phase 2]

View source ↗

Summary

Phase IIa study assessing efficacy and safety of AZD7624 in patients with chronic obstructive pulmonary disease on maintenance therapy has completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD7624

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease COPD | Phase 2 | Status: COMPLETED | Results posted: 2018-04-18